Cytokine-Induced CEACAM1 Expression on Keratinocytes Is Characteristic for Psoriatic Skin and Contributes to a Prolonged Lifespan of Neutrophils  by Rahmoun, Massilva et al.
Cytokine-Induced CEACAM1 Expression on
Keratinocytes Is Characteristic for Psoriatic Skin and
Contributes to a Prolonged Lifespan of Neutrophils
Massilva Rahmoun1, Jean-Pierre Mole`s2, Nathalie Pedretti3, Marc Mathieu1, Isabelle Fremaux4,
Nadia Raison-Peyron5, Jean-Claude Lecron6, Hans Yssel1 and Je´roˆme Pe`ne1
Carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) is a cell-surface glycoprotein,
belonging to the carcinoembryonic antigen family, expressed by human neutrophils, epithelial cells, activated T
and NK cells. CEACAM1 is expressed as a cell-surface molecule with different isoforms or can be secreted as a
soluble protein. Here, we show that keratinocytes in the outer epidermal layer of psoriatic skin express
CEACAM1, unlike those in healthy skin or in cutaneous lesions of patients with atopic or nummular dermatitis.
Stimulation of primary human keratinocytes or in vitro reconstituted epidermis with culture supernatants of
activated psoriatic lesion-infiltrating T cells, IFN-g or oncostatin M, but not IL-17, induced the expression of
transcripts for the CEACAM1-long and -short isoforms and cell-surface CEACAM1, whereas soluble CEACAM1
was not produced. The uppermost layers of the epidermis in psoriatic lesions also contain neutrophils, a cell
type with inflammatory and antimicrobial properties. Coculture of CEACAM1-expressing keratinocytes or CHO
transfectants with neutrophils delayed spontaneous apoptosis of the latter cells. These results show that
cytokine-induced cell-surface expression of CEACAM1 by keratinocytes in the context of a psoriatic
environment might contribute to the persistence of neutrophils and thus to ongoing inflammation and the
decreased propensity for skin infection, typical for patients with psoriasis.
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INTRODUCTION
Carcinoembryonic antigen-related cellular adhesion molecule 1
(CEACAM1; Beauchemin et al., 1999), formerly known as
Biliary glycoprotein, C-CAM or CD66a, is a member of the Ig
superfamily with a large spectrum of biological activities
(reviewed in Gray-Owen and Blumberg, 2006). CEACAM1
regulates cell proliferation (Singer et al., 2000), tumor growth
(Hsieh et al., 1995; Kunath et al., 1995), apoptosis (Huang et al.,
1999; Singer et al., 2005), angiogenesis (Ergun et al., 2000), T-
cell cytotoxicity (Morales et al., 1999), neutrophil (Skubitz et al.,
1996) and dendritic cell (Kammerer et al., 2001) functions,
lumen formation of epithelial cells (Huang et al., 1999),
extracellular matrix protein-specific morphology and migration
of endothelial cells (Mu¨ller et al., 2005). Furthermore, It has a
function in the adherence of activated neutrophils to cytokine-
activated endothelium (Kuijpers et al., 1992). Consistent with its
multiple effects on cellular function, human CEACAM1 is
expressed on a wide variety of cells in a wide range of normal
and malignant tissues, including granulocytes, activated T and
NK cells, transformed B cells, epithelial cells, extravillous
intermediate trophoblast cells (Bamberger et al., 2000),
endothelial cells, and several types of carcinomas (Prall et al.,
1996; Markel et al., 2002; Fahlgren et al., 2003). CEACAM1
also functions as a microbial receptor and binds opacity protein-
expressing Neisseria spp. (Virji et al., 1996; Chen et al., 1997;
Gray-Owen et al., 1997), outer membrane protein-expressing
Haemophilus spp. (Virji et al., 2000), and E. coli (Berger et al.,
2004), indicating its involvement in the recognition of bacteria
and the regulation of bacterial colonization. Although the
extracellular domains of CEACAM1 are heavily glycosylated,
making up more than half of its molecular weight, the non-
glycosylated-b sheet in the amino-terminal region of the
molecule is the target for the various bacterial adhesion
molecules and furthermore mediates the capacity of CEACAM1
to form homotypic intercellular interactions with itself, thereby
serving as its own ligand (Oikawa et al., 1992).
CEACAM1 mRNA is subject to extensive differential
splicing (Barnett et al., 1989). In human, 13 splice variants
have been detected, potentially resulting in the formation of
11 different proteins, although the function of each splice
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variant has not yet been validated. The two major splice
isoforms of CEACAM1 consist of either three or four
extracellular Ig-like domains that furthermore differ in their
cytoplasmic tails, thereby yielding short (CEACAM1-3S and
CEACAM1-4S) and long (CEACAM1-3L and CEACAM1-4L)
transmembrane isoforms, respectively (reviewed in Beauche-
min et al., 1999; Gray-Owen and Blumberg, 2006). The
relative expression levels of the L and S isoforms are not
static, vary significantly between cell types and are further-
more dependent on the state of activation of the cells (Singer
et al., 2000; Greicius et al., 2003; Scheffrahn et al., 2005).
Although expressed on a wide variety of epithelial cells
(Prall et al., 1996), little information is available on the
expression of the CEACAM1 isoforms on human epithelial
cells in the skin.
Keratinocytes are specialized cutaneous epithelial cells
that form four distinct layers in the epidermis, the outer layer
forming a selective barrier to the entry of foreign matter and
infectious agents into the body. In response to skin injury,
they release signaling molecules that modulate the expression
of cell-surface receptors on immune competent cells, thereby
modifying their cytoskeleton morphology and altering their
proliferative and migratory capacities. Alteration of such
complex interplay between epithelial and immune-compe-
tent cells is tightly associated with the pathogenesis of
Psoriasis vulgaris a common autoimmune disease. The self-
perpetuating activation of skin-infiltrating T lymphocytes
contributes to the epidermal hyperproliferation and abnormal
differentiation, characteristic for this disease, through the
secretion of various soluble factors and cytokines (Lowes
et al., 2007).
The aim of this study was to determine the regulation of
the expression of CEACAM1 and its isoforms by primary
epidermal keratinocytes in vitro and ex vivo, as well as its
possible involvement in the clinical manifestations of
cutaneous immune-mediated inflammatory disease.
RESULTS
Keratinocytes in the outer epidermal layer of psoriatic lesions
specifically express CEACAM1
The in situ expression of CEACAM1 in human skin biopsies
was determined by immunohistochemistry, using a mAb
suitable for in situ staining of CEACAM1, as validated by its
reactivity with primary melanoma cells that strongly express
this molecule (Figure 1a). Epidermal keratinocytes in any of
the healthy skin samples (n¼ 9) did not express CEACAM1,
although a few dermal cells were positive (Figure 1b). We
next analyzed whether epidermal keratinocytes under con-
ditions of cutaneous inflammation express CEACAM1.
Epidermal thickening and hyperproliferation of keratinocytes,
indicative of psoriasis, were accompanied by a strong
induction of CEACAM1 expression by these cells in the outer
keratinocyte layer of all psoriatic skin samples tested (Figure
1c; n¼ 24). Moreover, neutrophils present in the Munro-
Saboureau microabscess, a typical feature of psoriatic skin,
were strongly reactive with the anti-CEACAM1 mAb (Figure
1c). In contrast, no expression of CEACAM1 by hyperproli-
ferative keratinocytes of supratumoral epidermis (Figure 1a)
or by keratinocytes in the epidermis of atopic dermatitis
lesions (Figure 1d; n¼ 17) was observed, nor by those in the
epidermis of five patients diagnosed with nummular derma-
titis (Figure 1e). Although both psoriatic and atopic dermatitis
lesions contained large numbers of skin-infiltrating T cells in
the dermis, as indicated by positive staining with an anti-CD3
mAb (Figure 1f), few of these dermis-infiltrating cells were
found to express CEACAM1 (Figure 1c). Moreover, no
CEACAM1 expression by other cell types present in psoriatic
lesional skin, such as CD1aþ dendritic cells or Langerhans
cells (data not shown), was observed. Taken together, these
results demonstrate that keratinocytes in the outer epidermal
layer of psoriatic lesions specifically express CEACAM1 and
furthermore confirm that CEACAM1 is strongly expressed by
epidermotropic neutrophils.
Cytokines produced by T cells that infiltrate psoriatic lesions
induce CEACAM1 expression on normal primary keratinocytes
and on reconstituted human skin in vitro
The absence of expression of CEACAM1 by keratinocytes in
healthy skin, in contrast to its specific expression in the
context of psoriatic inflammation, suggests that its expression
might be subject to regulation by T cells that infiltrate this
particular inflammatory environment. As the pathology of
Figure 1. Keratinocytes in the outer epidermal layer of psoriatic lesions
specifically express CEACAM1. CEACAM1 expression on cutaneous biopsies
from individuals with (a) melanoma, from (b) healthy individuals, or patients
with (c) psoriasis, (d) atopic dermatitis, or (e) nummular dermatitis was
determined by immunohistochemistry analysis as described in ‘Materials and
Methods’. The presence of the Munro-Saboureau microabscess in the outer
layer of psoriatic skin (c) is indicated by *. Arrows indicate CEACAM1
expression in the dermis of (b) healthy individuals or patients with (d) atopic
or (e) nummular dermatitis. (f) CD3 expression in biopsies from patients with
psoriasis. Controls are inserted in the relevant figures. Scale bars¼100 mm.
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psoriasis has traditionally been associated with the activity of
T-helper (Th) type 1, IFN-g-secreting T lymphocytes, primary
skin-infiltrating T-cell lines generated from psoriatic lesions
were analyzed for their capacity to induce the expression of
CEACAM1 on normal human epidermal keratinocyte
(NHEK). Culture supernatants from these T-cell lines,
activated in vitro following stimulation with anti-CD3 and
anti-CD28 mAbs, strongly induced the expression of CEA-
CAM1 transcripts in NHEK with a maximal expression after
24 hours of incubation, as demonstrated by real-time RT-PCR
(Figure 2a). Moreover, NHEK cultured for 48 hours in the
presence of culture supernatants from activated psoriatic
skin-infiltrating T cells were found to express CEACAM1 at
their cell surface (Figure 2b). To determine whether T-cell-
produced cytokines, and in particular IFN-g, are involved in
the regulation of CEACAM1 expression on keratinocytes, the
culture supernatants were depleted of the latter cytokine
before their addition to NHEK. The elimination of IFN-g from
these culture supernatants almost completely abrogated their
CEACAM1 expression-inducing capacity, as shown by a
strong decrease in CEACAM1 mRNA (Figure 2a), as well as
the absence of protein expression at the cell surface (Figure
2b). Results from immunohistochemical analysis of NHEK,
cultured for 48 hours in the presence of IFN-g, directly
confirmed the capacity of this cytokine to induce a strong
expression of CEACAM1 on the latter cells (Figure 3a and b).
These results were substantiated by western blotting analysis
showing the expected molecular weight of about 140 kDa of
the induced protein in extracts from IFN-g-activated kerati-
nocytes (Figure 3c).
We have recently demonstrated that oncostatin M (OSM)
has potent modulatory effects on keratinocyte function
(Boniface et al., 2007). We therefore determined the capacity
of this cytokine to induce the expression of CEACAM1 on
either NHEK or on reconstituted human epidermis. Similar to
the effects of IFN-g, OSM-induced transcripts for CEACAM1
in NHEK and reconstituted epidermis (data not shown). In
contrast, the addition of IL-17, a cytokine produced by a
recently identified subpopulation of CD4þ T cells called
Th17 cells that are reportedly involved in the pathogenesis of
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Figure 2. Culture supernatants of activated skin-infiltrating T cells induce expression of CEACAM1 transcripts and protein by NHEK in an IFN-c-dependent
manner. (a) NHEK were cultured with different dilutions of supernatants of in vitro-activated skin-infiltrating T cells, depleted or not for the presence of IFN-g,
and the expression of CEACAM1 transcripts was analyzed by real-time RT-PCR following 24 hours of incubation. (b) NHEK were cultured in medium only
(Cont.) or in the presence of 30 or 5% culture supernatant, derived from psoriatic skin-infiltrating T cells, that had been activated for 24 hours in vitro with anti-
CD3 and CD28 mAbs (30% ND and 5% ND). In addition, supernatants depleted for the presence of IFN-g used at a concentration of 30% (30% D) or 5% (5% D)
were added in parallel. As a control, NHEK were stimulated with anti-CD3 and CD28 mAbs (CD3CD28). Expression of CEACAM1 was determined by
immunohistochemistry analysis after 48 hours of incubation. Scale bar¼ 100mm.
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several autoimmune and inflammatory disorders, did not
result in the induction of CEACAM1 transcripts (data not
shown). These results obtained at the transcriptional level
were confirmed by immunohistochemical analysis showing
that CEACAM1 expression was induced on reconstituted
epidermis cultured in the presence of OSM, but not in the
presence of IL-17 (Figure 4). The lack of CEACAM1
expression-inducing activity of IL-17 was also observed on
NHEK (Figure 5). Culture supernatants of the activated T cells
isolated from psoriatic lesions, used as a positive control in
these experiments, induced CEACAM1 expression on both
reconstituted skin (Figure 4) and NHEK (Figure 5).
Cytokine-activated keratinocytes express the CEACAM1-S
and -L isoforms, but do not produce soluble CEACAM1
Various splicing events of CEACAM1 mRNA can give rise to
the generation of three and four extracellular domains, in
combination with long and short cytoplasmic tails, as well as
soluble, isoforms. The ratio of CEACAM1-long and -short
isoform expression differs according to cell type and
activation state. We carried out both classic and real-time
RT-PCR analysis in order to determine which CEACAM1
isoforms are induced on keratinocytes. Transcripts for the 3S,
3L, 4S, and 4L isoforms were detected in NHEK, mainly
following culture with IFN-g or OSM, thus confirming results
showing cytokine-induced CEACAM1 protein expression on
keratinocytes (Figures 2–4). It is of note that although IL-17
was inactive by itself, it synergized with OSM in the
induction of each of the isoforms. Culture supernatants of
psoriatic lesion-infiltrating T cells strongly induced all four
CEACAM1 isoform transcripts, which was mainly dependent
on the presence of IFN-g, as shown by the depletion of the
latter cytokine using a specific mAb. As is shown in Figure 6b,
the primer combinations used in this study were specific for
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Figure 3. IFN-c induces cell-surface expression of CEACAM1 by NHEK. NHEK were cultured for 48 hours in the (a) absence or (b) presence of IFN-g. Cell-
surface expression of CEACAM1 was determined by immunohistochemistry (a, b) or western blotting analysis (c). Negative control for immunohistochemical
analysis is inserted in (b). Scale bar¼ 100mm.
Figure 4. OSM induces cell-surface expression of CEACAM1 on human
reconstituted epidermis. Human reconstituted epidermis was cultured for
48 hours in (a) the absence or (b) the presence of 30% T-cell-derived culture
supernatant, with (c) OSM or (d) IL-17, both at a concentration of 10 ng ml1.
The expression of CEACAM1 was determined by immunohistochemistry
analysis. Scale bar¼ 100mm.
Cont. T cell SN
IL-17IFN-γ
Figure 5. IL-17 does not induce CEACAM1 expression on NHEK. NHEK were
cultured in medium only (Cont.) or in the presence of either a culture
supernatant (30%, T-cell SN) of in vitro-activated psoriatic skin-infiltrating T
cells, IFN-g (10 ng ml1), or IL-17 and the expression of CEACAM1 was
analyzed by immunohistochemistry after 48 hours of incubation. Negative
controls for the two conditions that induce CEACAM1 expression are inserted
in the figures. Scale bars¼100 mm.
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each of the four isoforms. In order to directly determine
whether CEACAM1 isoform transcripts are overexpressed in
psoriatic skin, quantitative PCR analysis was carried out on
cutaneous samples taken from patients with psoriasis and
compared with those from nonpsoriatic individuals (n¼ 6).
However, no transcripts for either one of the four isoforms
could be detected, neither in the psoriatic skin samples, nor
in those from healthy nonpsoriatic skin. Finally, we deter-
mined the possibility that keratinocytes are able to produce
the soluble isoform of CEACAM1, by analyzing secreted
CEACAM1 levels in the culture supernatants of cytokine-
activated NHEK using CEACAM1-specific ELISA. No soluble
CEACAM1 was detectable in culture supernatants of NHEK,
stimulated for 48 hours with either IFN-g or with OSM
(Table 1), under the same experimental conditions that
induced the expression of CEACAM1 at the surface of these
cells. As expected, N-formyl-Met-Leu-Phe (fMLP)- or GM-
CSF-activated neutrophils, used as a positive control,
produced soluble CEACAM1.
Activated keratinocytes delay neutrophil apoptosis by
homotypic CEACAM1 interactions
Active P. vulgaris skin lesions are characterized by the
presence of neutrophils in the typical Munro-Saboureau
microabscess in the outer layer of the epidermis. As
neutrophils rapidly undergo apoptosis after having left the
circulation, we investigated whether CEACAM1-mediated
homotypic interactions between keratinocytes and neutro-
phils might contribute to the persistence of the latter cells in
this particular skin disease. Early and late apoptotic stages of
neutrophils, cultured in the presence or absence of CEA-
CAM1-expressing NHEK, were analyzed by measuring
Annexin-V binding and PI incorporation, respectively, using
flow cytometry. After 24 hours of coculture with NHEK about
55% of the neutrophils were in an early apoptotic state
(Figure 7c), which was similar to that of neutrophils cultured
in medium only (Figure 7a). In contrast, coculture of
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Figure 6. Cytokines produced by activated skin-infiltrating T cells induce the expression of CEACAM1-S and -L isoform transcripts on primary keratinocytes.
(a) NHEK were cultured for 24 hours with a combinations of cytokines, each used at a concentration of 10 ng ml1 or with a culture supernatant (30%) of in vitro-
activated psoriatic skin-infiltrating T cells, in the presence or absence of neutralizing mAbs specific for IFN-g or IL-17 and the expression of transcripts for the
short (3S and 4S) and long (3L and 4L) isoforms of CEACAM1 was analyzed by real-time RT-PCR. (b) The specificity of the primers for the different isoforms was
validated by classic PCR on NHEK, cultured in the presence of T-cell culture supernatant.
Table 1. Activated human keratinocytes do not
produce soluble CEACAM1
Culture conditions1 CEACAM1 (ng ml1)2
NHEK
Medium 0.57±0.42
IFN-g 1.21±1.15
OSM 0.95±0.86
Neutrophils
Medium 0.38±0.09
fMLP 10.26±0.31
GM-CSF 27.52±0.13
CEACAM1, carcinoembryonic antigen-related cellular adhesion molecule
1;NHEK, normal human epidermal keratinocytes; OSM, oncostatin M;
fMLP, N-formyl-Met-Leu-Phe.
1NHEK were cultured in medium alone or in the presence of IFN-g or
OSM (both at 10 ng ml1). As a control, freshly isolated peripheral blood
neutrophils were cultured in medium only or stimulated with fMLP
(108 M) or with GM-CSF (200 ng ml1).
2After 24 h, the culture supernatants were analyzed, by specific ELISA, for
the presence of soluble CEACAM1. Results of four independent
experiments (mean±SD).
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neutrophils with NHEK that had been preincubated with IFN-
g reduced the level of early apoptotic cells (30%) and
increased numbers of viable cells thus suggesting a protective
effect of CEACAM1-expressing NHEK (Figure 7d and h). To
more directly demonstrate the involvement of CEACAM1-
dependent interactions in this process, neutrophils were
cocultured with Chinese hamster ovary (CHO) cells expres-
sing either the 4S or the 4L isoforms of CEACAM1. Both
transfectants exerted a protective effect on neutrophils,
similar to that observed with CEACAM1-expressing NHEK
(Figure 7f and g) as compared to the wild-type nontransfected
CHO cell line (Figure 7e). GM-CSF, a factor known for its
ability to delay neutrophil apoptosis by promoting the growth
of these cells, which was added as a positive control,
significantly delayed spontaneous cell death after 24 hours of
culture (Figure 7b).
Finally, in order to determine whether the CEACAM1-
mediated effects were long lasting, neutrophils were cultured
for various periods of time in the presence of an anti-
CEACAM1 mAb or with GM-CSF. As expected, the protective
effect of GM-CSF was maintained until 66 hours of culture, as
a high percentage of viable neutrophils was still observed at
that time point (Figure 8b and e), as compared to the
experimental conditions using medium alone (Figure 8a and
e). CEACAM1 engagement by means of the addition of the
19.6 mAb also delayed spontaneous neutrophil apoptosis at
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Figure 7. IFN-c-induced expression of CEACAM1 on keratinocytes protects
neutrophils from spontaneous apoptosis. (a) One million of freshly isolated
peripheral blood neutrophils were cultured for 24 hours in medium alone or
(b) 200 ng ml1 GM-CSF or were cocultured with either NHEK that had been
preincubated for 48 hours (c) in medium, (d) with 10 ng ml1 IFN-g, or with (e)
wild type CHO cells or with CHO cells expressing (f) the long or (g) the short
isoform of CEACAM1. Frequencies of viable and early or late apoptotic cells
were determined by measuring Annexin-V binding (x axis) and PI
incorporation (y axis) using flow cytometry. Results shown in (a) to (g) are
representative of three independent experiments with neutrophils from
different donors and the percentages of cells in the quadrants are indicated in
each graph. (h) Percentages of viable cells are represented as the mean±SD.
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Figure 8. CEACAM1 engagement delays neutrophil apoptosis. One million
of freshly isolated peripheral blood neutrophils were either cultured (a) in
medium only, (b) with 200 ng ml1 GM-CSF, (c) with 30 mg ml1 of the anti-
CEACAM1 mAb 19.6, or (d) with 30 mg ml1 of an isotype control mAb for
various periods of time. Frequencies of viable and early or late apoptotic cells
were determined by measuring Annexin-V binding and PI incorporation using
flow cytometry. Representative results from four independent experiments
with neutrophils from different donors. Percentages of cells in the quadrants
are indicated. (e) Kinetics of viable cell frequencies are expressed as the
mean±SD of the values obtained in the four experiments.
676 Journal of Investigative Dermatology (2009), Volume 129
M Rahmoun et al.
Keratinocytes of Psoriatic Skin Express CEACAM1
least until 40 hours after the initiation of the cultures (Figure
8c) and even after 66 hours of culture, 4% of neutrophils were
still viable (Figure 8e), whereas the addition of an isotype
control IgG was ineffective (Figure 8d and e). Taken together,
these results indicate that CEACAM1-mediated homotypic
interactions between cytokine-activated keratinocytes and
neutrophils result in a delay in the spontaneous apoptosis in
the latter cells, although they do not prevent late apoptotic
events.
DISCUSSION
CEACAM1 is a well-studied member of a family of cell-
surface antigens that is involved in intercellular adhesion and
intracellular signaling events in normal as well as in cancer
cells and that furthermore has been reported to be important
as a regulatory receptor in immune responses of both myeloid
and lymphoid cells. Results from extensive histochemical
analysis on human tissue have shown that CEACAM1 is
expressed on most, if not all, types of epithelial cells (Prall
et al., 1996). However, we report here that keratinocytes in
normal, healthy skin do not express CEACAM1 and that its
expression is specifically upregulated under conditions of
inflammation in the outer epidermal layer of psoriatic skin.
CEACAM1 expression on activated keratinocytes is not
typical for cutaneous inflammation in general, as it could
not be detected in the epidermis of patients with atopic
dermatitis. Its specificity for psoriatic inflammation is
furthermore underscored by results showing that cutaneous
tissue from patients with nummular dermatitis does not
express CEACAM1. Therefore, its discrete expression pattern
makes CEACAM1 a useful biological and immunohistochem-
ical marker for the diagnosis of psoriasis.
The differential expression of CEACAM1 on keratinocytes
in cutaneous lesions of atopic dermatitis patients and those in
psoriatic lesions may reflect the underlying pathogenesis of
these skin disorders. It is generally accepted that the immune
response in atopic dermatitis is mediated by Th2 lympho-
cytes, contributing to the high IgE levels and eosinophilia
characteristic of this condition (Leung et al., 2004), whereas,
in contrast, Th1 cells are important in the pathogenesis of
psoriasis (Bowcock and Krueger, 2005). Moreover, recently a
separate lineage of Th cells has been identified, referred to as
Th17 cells that, by the production of IL-17, as well as IL-22, is
involved in the induction of autoimmune and inflammatory
disorders, such as psoriasis, inflammatory bowel disease, and
rheumatoid arthritis (review in Bettelli et al., 2007). There-
fore, the specific overexpression of CEACAM1 on keratino-
cytes in psoriatic lesions is most likely the consequence of the
particular cytokine production profile of these skin-infiltrating
T-lymphocyte subpopulations. Indeed, the induction of
CEACAM1 expression on keratinocytes was found to be
induced by culture supernatants of these cells and to involve
the activity of the classical Th1 cytokine IFN-g. Moreover,
OSM, recently reported by us and others to induce the
expression of several genes associated with the pathogenesis
of psoriasis (Wolk et al., 2006; Boniface et al., 2007), was
found to upregulate CEACAM1 expression on primary
keratinocytes. In contrast however, although IL-17 strongly
induces the expression of transcripts for b-defensins by
keratinocytes (Boniface et al., 2007), it does not have
CEACAM1 expression-inducing capacity, as determined
either by the direct addition of this cytokine to cultures of
NHEK (Figure 5) or to reconstituted human epidermis
(Figure 4).
The gene encoding CEACAM1 consists of 9 exons that can
be alternatively spliced to generate a total of 11 isoforms,
including 3 soluble forms referred to as CEACAM1-4C1,
CEACAM1-3, and CEACAM1-3C2 (review in Gray-Owen and
Blumberg, 2006). Although CEACAM1 molecules are able to
form homotypic interactions, it is not clear whether the
secreted CEACAM1 isoforms act as antagonists, thereby
interfering with membrane-bound CEACAM1 interactions, or
whether they are also capable to mediate CEACAM1-depen-
dent signaling following interaction with membrane-bound
CEACAM1. Results from a recent study have indicated that
activated rat granulocytes secrete soluble CEACAM1 (Singer
et al., 2005). Whereas human neutrophils, activated with fMLP
were found to secrete soluble CEACAM1 (Table 1), activated
keratinocytes, in spite of expressing membrane-bound CEA-
CAM1, did not secrete detectable levels of the soluble isoform
of CEACAM1 which therefore does not seem to be involved in
human keratinocyte-mediated biological effects.
In spite of the preferential expression of CEACAM1 in a
psoriatic inflammatory environment, there is however little
evidence for a direct implication in the pathogenesis of
psoriasis, as CEACAM1 is not expressed by keratinocytes that
constitute the main layer of cells undergoing hyperprolifera-
tion and abnormal differentiation in psoriatic lesions. We
therefore hypothesize that CEACAM1 could be involved in
another clinical aspect of psoriatic inflammation, that is in the
presence of neutrophils in the Munro-Saboureau microabs-
cesses which are located in the same outer epidermal layer as
the CEACAM1-expressing keratinocytes in psoriatic lesions.
Neutrophils, a cell type with strong inflammatory and
antimicrobial properties rapidly undergoes spontaneous
apoptosis once these cells have left the circulation. The
results of the present study show that coculture of cytokine-
activated keratinocytes with neutrophils delays spontaneous
apoptosis of the latter cells thereby confirming a, previously
published, similar effect on rat granulocytes, following
engagement of CEACAM1 by a specific mAb (Singer et al.,
2005), and thus suggest that homotypic CEACAM1-depen-
dent interactions are likely to contribute to a prolonged
presence of neutrophils in psoriatic skin.
As expected, GM-CSF was found to strongly delay
neutrophil apoptosis. It is has been reported that neutrophils
cultured in the presence of GM-CSF expressed increased
levels of CEACAM1 transcripts, as well as CEACAM1 protein
at their cell surface (Kobayashi et al., 2005). As epidermal
keratinocytes have been reported to produce GM-CSF
following activation (Kupper et al., 1988), they might
contribute to optimal homotypic CEACAM1 interactions,
not only between activated keratinocytes and neutrophils, but
also between neutrophils themselves, thus resulting in
enhanced and sustained inflammatory responses. It can
however not totally be excluded that cell-surface molecules
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other than CEACAM1 play a role in this process. The
persistence of neutrophils in psoriatic lesions might, in part,
explain the difference in the propensity for skin infection
between patients with psoriasis and atopic dermatitis.
Despite the presence of defective skin barriers in both types
of skin diseases, about one-third of all patients with atopic
dermatitis suffer from frequent skin infections (Kupper et al.,
1988), a complication only encountered in a minority of
psoriasis patients. This difference in susceptibility to skin
infection in patients with psoriasis has been associated with
the development of an adequate cutaneous innate immune
response, such as the secretion of b-defensins (Ong et al.,
2002), psoriasin or other antimicrobial peptides (Nomura
et al., 2003) by keratinocytes which is also under the control
of cytokines produced by activated T cells in particular IL-17
and OSM (Boniface et al., 2007). Neutrophils too, in
particular through the generation of reactive oxygen species,
are important in the killing of pathogenic microbial organ-
isms and their persistence at site of possible infection, as a
result of CEACAM1-mediated delay of apoptosis, may there-
fore be causally associated with lesser bacterial infection in
patients with psoriasis. CEACAM1 has been described as a
receptor for Hemophilus influenza and Neisseria spp. (Leusch
et al., 1991; Chen et al., 1997; Muenzner et al., 2000). The
involvement of CEACAM1 in the colonization of these
microbial organisms together with its specific expression by
keratinocytes in psoriatic lesions therefore seems to be in
contradiction with an increased resistance of psoriasis
patients to microbial infection. At present however, the
number of different microbial organism described to bind to
CEACAM1 is rather limited and those reported in the
literature have not been linked to the cutaneous infection
observed in patients with atopic dermatitis. Therefore, a
possible role for CEACAM1 in the colonization of microbial
organisms in cutaneous disorders characterized by ruptured
skin remains to be proven.
It is furthermore shown in this study that expression of
transcripts for all CEACAM1-L and -S isoforms is induced in
human keratinocytes by IFN-g and OSM, although with
different efficiency, and with the strongest effects displayed
by IFN-g. Nevertheless, at present, the functional significance
of the expression of these isoforms by activated keratinocytes
remains elusive. Finally, in spite of the association between
expression of CEACAM1 transcripts and protein in cytokine-
stimulated keratinocytes, no expression of any of the
CEACAM1 isoforms transcripts was detected in the cutaneous
biopsies of psoriatic patients. The most likely explanation is
that their expression is below levels of detection, because of
the restriction of CEACAM1 expression to the outer epidermis
layer of psoriatic skin, resulting in the dilution of the mRNA’s
in the entire samples.
Taken together, our results show that keratinocytes in the
outer layer of the epidermis in psoriatic lesions express
CEACAM1, thus forming a biological marker for the diagnosis
of this disease, and that the expression of the CEACAM1-L
and -S isoforms is induced in vitro on human keratinocytes by
IFN-g and OSM, both produced by T cells that infiltrate
psoriatic lesions. Although CEACAM1-mediated signaling
does not seem to be associated with abnormal keratinocyte
function in psoriasis, cytokine-induced cell-surface expres-
sion of CEACAM1 on keratinocytes in the context of a
psoriatic environment might contribute to the persistence of
neutrophils and thus ongoing inflammation, as well as to the
decreased propensity for skin infection, typical for patients
with psoriasis.
MATERIALS AND METHODS
Anti-CEACAM1 mAbs
The 19.6 mAb (IgG1) was generated following the immunization of
12 weeks old female BALB/c mice with the skin-derived T-cell clone
BOY-JF.161 (Lecart et al., 2001) and fusion of mouse spleen cells
with the myeloma line X-63 Ag-8. Culture supernatants of growing
hybridomas were tested by immunofluorescence and flow cytometry
and the corresponding mAb was selected for reactivity with a panel
of skin-derived T-cell clones, absence of reactivity with CD4þ
peripheral blood T cells and for suitability in western blotting and
immunoprecipitation procedures. The molecule recognized by the
19.6 mAb was identified by mass spectrometry and sequencing of
tryptic peptides. A Mascot search of 7 out of the 10 peptides
generated in this way permitted to identify with a probability score of
Po0.001 a peptide with the amino-acid sequence QIVGYAIGTQ-
QATPGPANSGR that is characteristic of human CEACAM1
(P13688). Moreover, the 19.6 mAb recognizes the expected
115 kDa glycoprotein on a 64 kDa protein backbone on activated
T cells, as shown by western blotting analysis (results not shown).
Finally, formal proof of the specificity of the 19.6 mAb for the
extracellular domain of CEACAM1 was provided by the observation
that CHO cells, transfected with cDNA encoding either the 4L or the
4S isoform of CEACAM-1 (see below), stained equally well with both
this mAb and the commercially available CEACAM1-specific mAb
MAB2244 (R&D Systems Europe, Lille, France; results not shown).
On the basis of sequence alignment of the transfected cDNA, it can
be concluded that the 19.6 mAb recognizes an epitope within the
sequence of the IgV-like domain between amino-acid residues 79
and 98 (results not shown).
Cells, cell culture, and cytokines
Primary T-cell lines were generated from cutaneous punch biopsies
of lesional skin of patients with P. vulgaris that had been cultured in
the presence of the anti-CD3- and anti-CD28 mAb-coated T-cell
Expander beads (Invitrogen Life Technologies, Cergy-Pontoise,
France), according to the manufacturer’s recommendations, and
expanded for 10–14 days in Yssel’s medium (Yssel et al., 1984),
supplemented with 1% human serum (Etablissement Franc¸ais du
Sang, Lyon, France) and 20 ng ml1 rIL-2 (Diaclone Research,
Besanc¸on, France) before use in experiments. The use of human
tissue was conducted according to the Declaration of Helsinki
principles, after written informed patient’s consent and was
approved by the ethical committee of the University Hospitals of
Montpellier. NHEK were isolated from foreskin, as reported in the
literature (Rheinwald and Green, 1977) and were cultured in
keratinocyte serum-free medium (K-SFM; Invitrogen Life Technolo-
gies), supplemented with epidermal growth factor (5 ng ml1) and
bovine pituitary extract (50 mg ml1; Invitrogen Life Technologies) at
37 1C, 5% CO2 in a humidified incubator. Peripheral blood
neutrophils were isolated from venous blood of healthy volunteers
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by percoll gradient centrifugation, resuspended in Hank’s balanced
salt solution and immediately used in experiments. CHO cells
transfected with cDNA encoding the long (NCBI database,
NM001712) or short (NM001024912) isoforms of CEACAM1 were
cultured in Iscove’s modified Dulbecco’s medium (IMDM), supple-
mented with 10% fetal calf serum (Biowest, Nuaille, France) and
300mg ml1 of G418 (Invitrogen Life Technologies). The following
recombinant cytokines were used IFN-g, IL-17, and OSM (final
concentration 10 ng ml1; R&D Systems).
Reconstituted human skin
Reconstituted human skin was generated as described previously
(Moles et al., 1994). Briefly, keratinocyte suspensions (2 105 cells
in 15ml) were seeded on the center of a dead, de-epidermized
dermis and grown at the air–liquid interface on a metallic support for
2 weeks at 37 1C, 5% CO2 in a humidified incubator. Culture
medium consisted of Ham’s F12/DMEM (1/3; v/v), supplemented
with 10% fetal calf serum, 1% penicillin/streptomycin, 1%
fungizone (Invitrogen Life Technologies), 0.4mg ml1 hydrocorti-
sone, 5mg ml1 insulin, 1010 M cholera toxin, and 10 ng ml1 EGF
(Sigma-Aldrich, Saint-Quentin-Fallavier, France). The culture med-
ium was supplemented with the various cytokines during the 2
weeks of reconstruction.
Generation of T-cell culture supernatants
Primary T-cell lines were washed extensively in serum-free medium
without any supplements and were cultured at a concentration of
2 106 cells ml1 in the same culture medium in the presence of
plate-bound anti-CD3 (SPV-T3b; Beckman-Coulter, Roissy, France;
coated for 4 hours at 37 1C at a concentration of 10mg ml1 in
phosphate-buffered saline, PBS) and anti-CD28 (L293; BD Bios-
ciences, Le Pont de Claix, France; 1mg ml1) mAbs. Controls
consisted of culture medium incubated only with the latter mAbs
and were used to evaluate possible nonspecific activation of the
keratinocytes. Culture supernatants were collected after 24 hours of
culture and following removal of remaining cells by centrifugation,
aliquoted and stored at 80 1C before use. Depletion of IFN-g from
the culture supernatants was carried out as follows: 250ml of goat-
anti-mouse IgG Ab-coated magnetic beads (Dynal, Compie`gne,
France) were incubated with 100ml of the neutralizing anti-human
IFN-gmAb BB-1 (1 mg ml1; Diaclone Research) or anti-human IL-17
mAb (1 mg ml1; R&D Systems) for 30 minutes at 4 1C under orbital
shaking. After washing with PBS containing 2% fetal calf serum, the
mAb-coated beads were incubated with 1 ml of T-cell-derived culture
supernatant for 30 minutes at 4 1C under orbital shaking. After
removal of the beads by a magnetic device (Invitrogen Life
Technologies), the culture supernatant was used directly in experi-
ments. This procedure allows the complete and specific removal of a
cytokine from the culture supernatant, as determined by cytokine-
specific ELISA following depletion (unpublished observations).
Immunofluorescence and flow cytometry analysis
All immunofluorescence and flow cytometry procedures were
carried out as described (Scheffold et al., 2002). In addition to the
anti-CEACAM-1 mAbs referred to above, the following (m)Abs and
control IgG were used: nonconjugated anti-CD3 mAb SPV-T3b,
nonconjugated anti-CD25 mAb, and nonconjugated mouse IgG1 as
isotype-specific negative control (BD Biosciences); PE-conjugated
anti-CD4 and a FITC-conjugated goat-anti-mouse IgG Ab (Caltag, Le
Perray-en-Yvelines, France). Cells were analyzed on a FACSCalibur
flow cytometer equipped with Cellquest software (BD Biosciences).
RNA isolation and quantitative RT-PCR analysis
Total cellular RNA from keratinocytes was extracted using
Tri-Reagent (Sigma-Aldrich; T9424) following the manufacturer’s
protocol. Total RNA was reverse-transcribed using the primer
oligo(dT) and Superscript II enzyme (Invitrogen Life Technologies).
cDNAs, were subsequently analyzed by quantitative real-time PCR
using the LightCycler system (Roche Diagnostics, Meylan, France),
as described originally by Wittwer et al. (1997), as well as classic
PCR. Primer sequences were: Homo sapiens CEACAM1-4S
(NM001024912): sense—AAACCAGAGTCTCCCGTCCT, antisense—
TGGAGTGGTCCTGAGCTGCCG; CEACAM1-4L (NM001712):
sense—AAACCAGAGTCTCCCGTCCT, antisense—TTGTGCTCTGT
GAGATCACGC or antisense—GTGGTTGGAGACTGAGGGTTTG;
CEACAM1-3S (AY766113): sense—TCACTGATAATGCTCTACCAC
AAGA, antisense—TGGAGTGGTCCTGAGCTGCCG: CEACAM1-3L
(X14831): sense—TCACTGATAATGCTCTACCACAAGA, antisense—
TTGTGCTCTGTGAGATCACGC or antisense—GTGGTTGGAGAC
TGAGGGTTTG. The different combinations of these primers were
used to amplify the individual CEACAM1 isoforms. The calculated
amount was normalized to the housekeeping gene glyceraldehyde-
3-phosphate dehydrogenase.
Immunohistochemical staining
Punch biopsies from lesional skin of patients with psoriasis (n¼ 24)
or with atopic dermatitis (n¼ 17) were collected, immediately
embedded in OCT-compound (Miles, Zoeterwoude, the Nether-
lands), frozen in liquid nitrogen precooled isopentane and stored at
80 1C until immunohistochemical analysis. Healthy control skin
samples (n¼ 9) were obtained from plastic surgery procedures or
from routine circumcisions. Patients enrolled in this study did not
receive treatment for their disease at the time of collection. All
patients and healthy individuals provided informed consent and the
procedures were carried out in accordance with the guidelines of the
ethical committee of the Montpellier University Hospitals. Sections
of cutaneous biopsies (6mm) were obtained, using a cryomicrotome
(Leica, Wetzlar, Germany), fixed with 3.7% formaldehyde/PBS for
10 minutes and incubated with 3% H2O2 in PBS for 10 minutes
followed by blocking with PBS containing 0.1% gelatin, for 2 hours
in a humidified chamber. Then sections were incubated overnight
at 4 1C with the anti-CEACAM1 mAb 19.6 and the anti-CD3 mAb
T3-4b5 (Dako SA, Trappes, France). Slides were processed for
immunoperoxidase staining using the Dako ChemMate detection kit
(Dako). Negative controls were carried out by omission of the
primary antibody. Sections were then examined with a TE300
microscope equipped with a DMX1200 digital camera (Nikon,
Tokyo, Japan). For the staining of monolayered NHEK, the cells were
first cultured on coverslips and then processed as above. No
permabilization step was applied in this protocol.
Western blotting analysis
NHEK were lyzed using Triton X-100 lysis buffer for 1 hour on ice.
For western blotting analysis, protein extracts were boiled in SDS
buffer, before their loading onto a 10% nonreducing SDS-PAGE gel.
After electrotransfer to PVDF membranes (Millipore, Bedford, MA)
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and blocking in saline buffer, containing 0.1% Tween-20 and 5%
nonfat milk for 1 hour, blots were incubated overnight with the 19.6
or an anti-GAPDH mAb (Santa Cruz Biotechnology, Santa Cruz,
CA). The presence of proteins was revealed by incubation with
peroxidase-conjugated goat-anti-mouse IgG (ImmunoResearch
Laboratories, West Grove, PA) and detection using the ECL advance
western blotting detection kit (GE Healthcare, UK).
Measurement of production of cytokines and soluble CEACAM1
The presence of IFN-g in culture supernatants was determined by
cytokine-specific ELISA, as described (Pe`ne et al., 2006). Soluble
CEACAM1 measurements were carried out according to a similar
procedure, using the anti-CEACAM1 mAb 19.6 as the capture
antibody (2mg ml1) and a biotinylated goat anti-recombinant
CEACAM1 Ab (R&D Systems; BAF2244) as the detection antibody
(0.1 mg ml1). Streptavidin-AP (BD Pharmingen, Le-Pont-de-Claix,
France; dilution 1/10,000) and the substrate 4-nitro-phenyl phos-
phate (Sigma-Aldrich) was used as the read-out. Recombinant
CEACAM1 (R&D Systems) was used to establish a standard curve.
The sensitivity of the assay was 300 pg ml1.
Analysis of neutrophil apoptosis
One million freshly isolated peripheral blood neutrophils were
added to confluent layers of either NHEK, precultured in the absence
or presence of 10 mg ml1 IFN-g, to CEACAM1-L- or CEACAM1-S-
expressing CHO cells or to nontransfected CHO cells, respectively,
and the cells were cultured for various periods of time at 37 1C in a
final volume of 1 ml. Alternatively, neutrophils were stimulated with
the 19.6 mAb (1mg ml1), fMLP (108 M; Sigma-Aldrich) or GM-CSF
(200 ng ml1; R&D systems). Neutrophil apoptosis was measured by
a procedure based on double-staining with FITC-Annexin-V (early
apoptosis) and PI (late apoptosis), thus identifying early apoptotic
cells as Annexin-Vþ , PI, late apoptotic cells as Annexin-Vþ , PIþ ,
and viable cells as Annexin-V, PI using the Bender Medsystems
apoptosis kit (Tebu, Le Perray-en-Yvelines, France) on a FACSCalibur
flow cytometer equipped with Cellquest software (BD Biosciences).
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